Aric has over 20 years of experience in the pharmaceutical industry. In his recent position at Teva’s R&D , Aric managed the pharmacology department responsible for investigating the MoA and therapeutic benefit of novel drug candidates in ddevelopment. Prior to that, Aric served as a project leaderr in the R&D where he oversaw the full scope of development activity . He began his career at Teva in the toxicological department . Aric brings knowledge of pre-clinical development for novel drug candidates from the discovery phase , through IND , up to product registration. His is experienced with the conduct of in vitro and vivo models to support the development of novel therapeutics. Aric majored in Biology (BSc.) and Veterinary medicine (DVM) at the Hebrew university and holds an MBA from Peres Academic Center.